MASP-2 inhibition as a potential strategy for the management of IgA nephropathy DRUGS OF THE FUTURE Barratt, J., Lafayette, R. 2020; 45 (6): 389–96

View details for DOI 10.1358/dof.2020.45.6.3115216

View details for Web of Science ID 000538615500003